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A rapid method of
monitoring the acute phase
response in a rat model
I M Moodie, D Labadarios
The acute phase response (APR) is accompanied by major
changes in micronutrient status. It is important to be able
to quantitate the degree of APR, which can then be related
to the accompanying alterations in micronutrient levels.
A rapid and convenient means of achieving this, viz. the
use of an animal model in which APR can be induced,
would facilitate such an investigation.
The aim of the present study was to establish, by means
of a rat model, a rapid procedure to identify APR which is
less time-consuming and less expensive than the more
traditional enzyme-linked immunosorbent assay and radio-
immunoassay.
Blood was drawn immediately prior to, and at 24, 48, 72
and 96-hour intervals post-inducement of the acute phase.
The serum was deproteinised and treated with a dye,
Auramine 0, which specifically binds the acute phase
protein (Xl-acid glycoprotein (AAG), the latter remaining in
solution after deproteinisation. The product formed is a
fluorescent addition compound. With fluorescence
spectrophotometry, levels of AAG were determined and
the extent of APR monitored.
A progressive and reproducible increase in AAG was
observed, the highest fluorescence intensity recorded
after 48 hours; this indicated a mean value (N = 5) of
9.4 mg/ml from zero at baseline. With a spiking approach,
a mean AAG recovery of 96% was obtained.
The validated methodology, less expensive and less
time-consuming than existing procedures, which rapidly
detects AAG in rat serum, provides a simple technique for
monitoring the APR process in these animals.
S Afr Med J 1997; 87: 100-102.
FollOWing inflammatory stimuli (e.g. tissue injury or infection),
a number of important biochemical changes, known
collectively as the acute phase response (APR), take place.
This response includes major changes in both macronutrient
and micronutrient status, which have made it difficult to
interpret blood micronutrient concentrations in acutely ill
patients. It is important, therefore, to be able to quantitate the
extent and degree of the APR which can then be related to
accompanying alterations in micronutrient levels. Among the
changes that occur are those in the serum levels of several
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proteins originating in the liver; these are known as the acute
phase proteins. The extent of the APR is quantitatively
reflected by these changes which may be used to monitor its
severity. Thus, we aimed to develop a rat model in which
determination of the acute phase protein, et, -acid glycoprotein
(AAG), would form the basis of such a monitor.
Determination of human acute phase protein levels in vitro
and in vivo is often based on the use of enzyme-linked
immunosorbent assay (ELlSA) techniques, but mostly
involves radial immunodiffusion or immuno-electrophoresis
that requires specific antibodies. For similar studies that
involve animals, such antibodies are not commercially
available and therefore have to be experimentally produced,
an expensive and time-consuming exercise. To avoid this,
we sought a- more convenient method of determining AAG
levels in rat plasma.
A previous report' on the binding of basic drugs to human
AAG describes a rapid and simple fJuorimetric technique for
the determination of AAG concentrations in serum. Our
objective was to apply a similar procedure to plasma drawn
from rats at regular intervals following the experimental
induction of the APR.
Materials and methods
Purified rat AAG was obtained from 5igma Chemical Co.,
St louis, USA, and 2 mg were dissolved in 0.13 M
potassium phosphate buffer (pH 7.4) (400 ~I). Four aliquots
of 6 ~I, 40 ~l, 75 ~I and 120 ~I were each made up to 200 ~I
with the same buffer and used to establish a calibration plot
of fluorescence intensity against concentration, using a
Perkin-Elmer model 204A fluorescence spectrophotometer.
Auramine 0 (Colour index no. 41000) was obtained from
Merck, Darmstadt, Germany, and a 0.5 mM solution
prepared in ethanol (1.58 mg/ml). Sulphosalicylic acid
(SOH Ltd, Poole, England) was used as a protein precipitant
(6% weight/volume in water). Heparin sodium solution
containing 5 000 IU/ml (Intramed, Port Elizabeth, South
Africa) was used to prevent clotting of freshly drawn blood
and consequent blockage of the syringe needle. 0.13 M
potassium phosphate buffer (pH 7.4) (100 ml) mixed with
2 M sodium hydroxide (1.65 ml), to give solution A, was
freshly prepared for each assay. Oil of turpentine was
obtained from Heyns Mathew, Cape Town, South Africa.
Three groups of five male Wistar rats (approXimately
250 g) from an inbred colony (Medical Research Council)
were confined in three plastic cages, in an air-conditioned
and humidity-controlled room at approximately 22<lC
(12-hour light/dark cycle) and with continuous free access to
food (standard pellet diet obtained from Specialist Animal
Feeds, Cape Town) and water. Each group of rats was
successively subjected to the following experimental
protocol.
Table I. Recovery of AAG from rat serum
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Blood (approximately 1 ml) was withdrawn from the tail
vein With a 0.5 ml plastic disposable insulin syringe
(29-9auge needle, 13 mm long) containing heparin sodium
solution (1 - 2 ~I). The blood samples (in Eppendorf tubes)
were chilled on ice and immediately centrifuged (Microfuge,
Beckman Instruments, Cape Town) at 4°C. Plasma was
removed and stored at -200G until required for analysis. Oil
of turpentine (1 ml) was injected subcutaneously, as two
equal aliquots into two sites in the dorsolumbar region, so
as to induce an inflammatory response;2 subsequent blood
samples were similarly drawn at 24, 48, 72 and 96-hour
intervals post-injection and treated as already described.
Aliquots (200 !Jl) of the different standard solutions or rat
plasma were treated with 6% sulphosaJicylic acid solution
(200 !Jl), stirred thoroughly for 10 seconds on a vortex mixer,
placed on ice for 5 minutes and centrifuged for 5 minutes.
Supernatant (300 ~I) was transferred to small glass tubes
containing solution A (2 ml) and stirred as described above.
The mixture was carefully transferred to a cuvette and the
baseline fluorescence was measured (excitation and
emission wavelengths 470 and 550 nm, respectively).
Auramine 0 in ethanol (40 1J1) was added to the contents of
each cuvette and carefully mixed. Fluorescence intensity
was again measured using the same wavelength settings.
A calibration plot based on the difference in fluorescence
intensity against MG concentration was established (Fig. 1)
with the standard solutions, and used to determine levels of
AAG in plasma samples.
Two 200 IJI aliquots of rat plasma were spiked with·
phosphate buffer solution of AAG - 40 ~I; 0.2 mg and 75 ~I;
0.375 mg, respectively. These spiked plasma samples, along
with an aliquot (200 jJl) of the corresponding unspiked
plasma, were taken through the procedure as described
above. Difference in fluorescence intensity was recorded
(Table I), together with corresponding observed weights of
MG in the samples. The latter were then corrected for a
sample volume of 200 JJI and the weights of MG in the two
spiked samples recovered were calculated from their
difference from the unspiked sample. The values thus
obtained for the AAG recovered were then compared, in
each case, with the weights of AAG originally added, after
which the recovery was calculated.
Discussion
Human AAG has been shown to bind basic drugs in serum
and has been the subject of studies on interpretation of their
pharmacokinetic data.J ,4 Additionally, several reports have
described the importance of measuring AAG levels and
methods for doing so.5-lI The use of a fluorescent probe to
obtain information on the interaction between proteins and
small molecules9•1G is based on the observation that an
aqueous solution of the probe, when added to a solution of
a major binding protein, results in the formation of an
AAG spike Sample Ruorescent Corrected weight Calculated Recovery
added (mg) volume ijJl) intensity liNT. AAG mg) AAG (mg/200 ~l) spike (mg) %
200 8 (0.140) 0.140
0.2 240 13 (0.405) 0.338 0.198 99
0.375 275 18 (0.665) 0.484 0.344 92
SAMJ Volume 87 No. 1 January 1997 ___
addition compound which fluoresces strongly, whereas the
two components individually do not fluoresce or do so only
very weakly. This has been extended to the determination of
AAG in human serum using Auramine 0 as the probe_
In addition to AAG. Auramine 0 reacts with albumin and,
to a lesser extent, gamma-globulin, forming the
corresponding fluorescent addition compounds.
Consequently. before AAG determination. removal of these
proteins is necessary; this was achieved by selective
sulphosalicylic acid precipitation' based on a procedure for
isolating AAG from human serum.
The methodology described here has been developed as
a rapid and more convenient alternative to more traditional
procedures for 1J10nitoring the APR in the rats.
Results
40
(9.4
30
(6.6)
20
(3.9
10
(1.3)
>-- T
"y
,
1
Fig. 2. Fluorescence intensity and AAG levels in rat plasma v. post
turpentine injection time. (Each data point is the mean of five
values. Overall means from the three experiments are plotted as
a solid line with SEM error bars.)
POST INJECTION TIME (HRS)
This procedure for AAG determination involves a differential
measurement of fluorescence intensity obtained from readings
taken before and after the addition of Auramine 0 to standard
solutions of rat AAG. The standard calibration plot of this data
(Fig. 1) shows a linear relationship (r' ~ 0.982) between rat
AAG concentration and differential fluorescence intensity,
similar to that previously reported' for human AAG, including
the same tendency to underestimate AAG concentration, as
shown by the negative intercept on the ordinate.
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We have validated a methodology that is convenient, less
expensive and less time-consuming than existing
procedures, which rapidly detects AAG in rat plasma,
thereby providing a simple technique for monitoring the APR
process in these animals.
The method was also tested on samples of a rat plasma
spiked with rat AAG at two different levels_ When compared
with corresponding unspiked samples (Table I), the data
indicate a mean AAG recovery rate of 96%..
Conclusion
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Fig. 1. Standard curve for the measurement of rat AAG using the
Auramine 0 method.
This methodology was then applied to the monitoring of
AAG levels in plasma samples drawn from rats immediately
prior to their injection with turpentine and again at 24, 48, 72
and 96-hour intervals thereafter. A progressive and
reproducible increase in AAG was observed with a maximum
level reached between 48 and 72 hours post-injection (Fig. 2).
The level of AAG observed in this study (highest mean value
9.4 mglml from zero at baseline) is considerably higher than
that reported by Schreiber et al.' in rats (3.2 mg/ml from 0.17
mglml at baseline). The latter may be related to the difference
in the intensity of the APR induced. The experiment was
successively repeated sequentially on two further groups of
rats with similar results (Rg. 2), though the one group, in
response to the same stimulus, surprisingly produced less
AAG than either of the other two.
REFERENCES
T Sugiyama Y, Suzuki Y, Sawada Y, et al. Auramine 0 as a fluorescent probe for the
binding of basic drugs to human a,-acid glycoprotein (a,-AG). Biochem
Pharmacal 1985; 34: 821-829.
2. Schreiber G, Howlen G, Nagashima M, et al. The acute phase response of
plasma protein synthesis during e:o.perimental inflammation. J Bioi Chem 1982;
251: 10271-10277.
3. Piafsky KM. Disease induced changes in the plasma binding of basic drugs. CUn
Pharmacokiner 1gaO; 5: 246-262.
4. Uma JJ. Boudoulas H, Blanford M. Concenuation-dependence of disopyramide
binding to plasma protein and its influence on kinetics and dynamics. J
Pharmacol Sip Ther 1981; 219: 741-747.
5. Romach MK, Piafsky KM, Abel JG, et aI_ Methadone binding to orosomucoid
{alpha 1-acid glycoprotein): delelminanl of tree fraction in plasma. CUn
Pharmacal Ther 198T; 29: 211-217.
6. Piafsky KM, 80rga O. Odar-Cederlof I, et al. Increased plasma protein binding 01
propranolol and chlorpromazine mediated by disease-induced elevations of
plasma alpha t -acid glycoprotein. New Engl J Med 1978; 299: 1435-1439.
7. Pia/sky KM, Borga O. Plasma protein binding of basic drugs. 11. Importance of
alpha 1-acid glycoprotein for interindividual variation. Clin Pharmacol Ther 1977;
22.: 545-549.
8. Routledge PA, Barchowsky A. Bjornsson TO, er al. Udocaine plasma pl'oteio
binding. Clin Pharmacol Ther 1980; V: 347-351.
9. Wang JL, Edelman GM. AUOl'escent probes for conformational stales of proteins.
IV. The pepsinogen-pepsin conversion. J Bioi Chem 1971; 246: 1185-1191.
10. Sugiyama Y, Yamada T, Kaplowitz N. Newly identified organic anionic-binding
proteins in rat liver cytosol. Biochim Biophys Acta 1982; 709: 342-352.
.. Volume8? No. 1 January 1997 SAMJ
